Seroprevalence of Infectious Respiratory Agents in Thoroughbred Race Horses at the Seoul Race Park,  Republic of Korea

Sang-Kyu Lee; Andrew Stephen Waller; Dongsun Park

doi:10.4167/jbv.2022.52.3.128

All Issue

2022 Vol.52, Issue 3 Preview Page

Original Article

Seroprevalence of Infectious Respiratory Agents in Thoroughbred Race Horses at the Seoul Race Park, Republic of Korea

30 September 2022. pp. 128-135

PDF XML

Abstract

Infectious respiratory disease is one of the most frequent causes of lost days in training and reduced performance of Thoroughbred racehorses. Equine influenza virus (EIV), Equine herpesvirus-1 (EHV-1) and -4 (EHV-4), equine rhinitis virus A (ERAV) and B (ERBV), and Streptococcus equi subspecies equi (S. equi) are important infectious agents of the respiratory tract of horses. The purpose of this study was to determine the seroprevalence of EHV-1, EHV-4, ERAV, ERBV, and S. equi and to measure EIV antibody levels of Thoroughbred racehorses at Seoul Race Park (SRP), Republic of Korea. All horses had previously been vaccinated against EIV and S. equi, but not against any of the other pathogens that were tested. A total of 94 serum samples, which were collected from race participants at the SRP were tested using the single radial haemolysis (SRH) test for EIV (H3N8), the complement-fixation (CF) test for EHV-1, EHV-4, ERAV, ERBV and an indirect enzyme-linked immunosorbent assay (iELISA) for S. equi. Serum samples from seventy eight out of 94 horses (83%) generated zones of over 85 mm² in the SRH test, which classified them as clinically protected against EIV (H3N8). The most sero-prevalent agent detected was EHV-4 (30.9%, 29/94), followed by EHV-1 (9.6%, 9/94), S. equi (2.1%, 2/94), ERAV (1.1%, 1/94) and ERBV (1.1%, 1/94). All horses showed no visual clinical signs. The present study showed that the seroprevalence of infectious respiratory agents was relatively low and provides evidence of low risk of respiratory infectious agents in Thoroughbred race horses at SRP.

Keywords

Seroprevalence

Thoroughbreds

EHV-1

EHV-4

Performance

References

Ko S, Kang JG, Yeh JY, Moon JS, Choi GC, Won S, et al. First Report on Molecular Detection of Equine Upper Respiratory Infectious Viruses in Republic of Korea. J Equine Vet Sci 2013;33:628-36.

10.1016/j.jevs.2012.11.001

Morley PS, Pusteria N. Viral respiratory disease in athletic horses. In: Hinchcliff KW, Kaneps AJ, Geor RJ, editors. Equine Sports Medicine and Surgery: Basic and clinical sciences of the equine athlete 2 ed, London: Elsevier Health Sciences; 2014. p.649-60.

10.1016/B978-0-7020-4771-8.00030-2

Back H, Weld J, Walsh C, Cullinane A. Equine Rhinitis A Virus Infection in Thoroughbred Racehorses-A Putative Role in Poor Performance? Viruses 2019;11:963.

10.3390/v1110096331635401PMC6848918

OIE. 2019. Equine influenza (Infection with equine influenza virus). In: OIE Terrestrial Manual 2019. World Organization for Animal Health, Paris, France, Available at https://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/3.06.07_EQ_INF.pdf. (accessed March 22, 2022).

Patel JR, Heldens J. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review. Vet J 2005;170:14-23.

10.1016/j.tvjl.2004.04.01815993786

Yildirim Y, Yilmaz V, Kirmizigul AH. Equine herpes virus type 1 (EHV-1) and 4 (EHV-4) infections in horses and donkeys in northeastern Turkey. Iran J Vet Res 2015;16:341-4.

OIE. 2018. Equine rhinopneumonitis (Infection with equid heresvirus-1 and -4). In: OIE terrestrial manual 2018. World Organization for Animal Health, Paris, France, Available at https://www.oie.int/fileadmin/Home/eng/Health_standards/ tahm/3.06.09_EQUINE_RHINO.pdf. (accessed March 22, 2022).

Horsington J, Lynch SE, Gilkerson JR, Studdert MJ, Hartley CA. Equine picornaviruses: well known but poorly understood. Vet Microbiol 2013;167:78-85.

10.1016/j.vetmic.2013.05.01223820049

NAHMS. 2001. Infectious Upper Respiratory Disease in U.S. Horses: Disease Frequency. In: USDA, Available at https://www.aphis.usda.gov/animal_health/nahms/equine/downloads/equine98/Equine98_is_IURD.pdf. (accessed 22 March, 2022).

Scott Pirie R. One is good ... two are better: breaking the 'stranglehold' of asymptomatic carriers on Streptococcus equi dissemination? Vet J 2013;197:527-8.

10.1016/j.tvjl.2013.04.02923769455

Robinson C, Steward KF, Potts N, Barker C, Hammond TA, Pierce K, et al. Combining two serological assays optimises sensitivity and specificity for the identification of Streptococcus equi subsp. equi exposure. Vet J 2013;197:188-91.

10.1016/j.tvjl.2013.01.03323465547

Fraipont A, Van Erck E, Ramery E, Richard E, Denoix JM, Lekeux P, et al. Subclinical diseases underlying poor performance in endurance horses: diagnostic methods and predictive tests. Vet Rec 2011;169:154.

10.1136/vr.d414221795311

Ryu SH, Koo HC, Park YK, Kim JM, Jung WK, Davis WC, et al. Etiologic and immunologic characteristics of thoroughbred horses with bacterial infectious upper respiratory disease at the Seoul Race Park. J Microbiol Biotechnol 2009;19:1041-50.

10.4014/jmb.0812.67019809264

Traub-Dargatz JL, Dargatz DA, Morley PS, Dwyer R, Landry K. Infection control strategies for horses in the new millennium. AAEP 2001;47:36-40.

Korea Racing Authority. Thoroughbred report, 2022 Available at https://studbook.kra.co.kr/neweng/html/eng_bhr_ reg_tonggye3.jsp (accessed March 22, 2022).

Korea Racing Authority. KRA racing statstics, 2022 Available at https://race.kra.co.kr/globalEn/racingStatistic.do (accessed March 22, 2022).

Slater J. Equine Herpesviruses. In: Sellon DC, Long MT, editors. Equine Infectious Diseases 2nd ed, St. Louis, USA: W.B. Saunders; 2013. p.151-68.

10.1016/B978-1-4557-0891-8.00014-232878380

Boyle AG. Streptococcus equi ss equi. In: Pusterla N, Higgins J, editors. Interpretation of Equine Laboratory Diagnostics 1st ed, Hoboken, USA: Wiley; 2018. p.165-9.

10.1002/9781118922798.ch2929693045PMC5904046

Waller AS, Sellon DC, Sweeney CR, Timoney PJ, Newton JR, Hines MT. Streptococcal Infections. In: Sellon DC, Long MT, editors. Equine Infectious Diseases 2nd ed, St. Louis, USA: W.B. Saunders; 2013. p.265-77.

10.1016/B978-1-4557-0891-8.00028-2

Sack A, Cullinane A, Daramragchaa U, Chuluunbaatar M, Gonchigoo B, Gray GC. Equine Influenza Virus-A Neglected, Reemergent Disease Threat. Emerg Infect Dis 2019;25:1185-91.

10.3201/eid2506.161846PMC6537720

Thomson GR, Mumford JA, Campbell J, Griffiths L, Clapham P. Serological detection of equid herpesvirus 1 infections of the respiratory tract. Equine Vet J 1976;8:58-65.

10.1111/j.2042-3306.1976.tb03291.x177281

Gildea S, Arkins S, Cullinane A. A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus. Influenza Other Respir Viruses 2010;4:363-72.

10.1111/j.1750-2659.2010.00163.x20958930PMC4634612

Newton JR, Townsend HG, Wood JL, Sinclair R, Hannant D, Mumford JA. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Vet J 2000;32:65-74.

10.2746/04251640077761211610661388

Crossley B, Hill A. Alpha-Herpesviruses (EHV-1, EHV-4). In: Pusterla N, Higgins J, editors. Interpretation of Equine Laboratory Diagnostics 1st ed, Hoboken, USA: Wiley; 2018. p.153-4.

10.1002/9781118922798.ch26

Wood JLN, Newton JR, Chanter N, Mumford JA. Inflammatory airway disease, nasal discharge and respiratory infections in young British racehorses. Equine Vet J 2005;37:236-42.

10.2746/042516405453057915892233

Back H, Penell J, Pringle J, Isaksson M, Ronéus N, Treiberg Berndtsson L, et al. A longitudinal study of poor performance and subclinical respiratory viral activity in Standardbred trotters. Vet Rec Open 2015;2:e000107.

10.1136/vetreco-2014-00010726392904PMC4567161

Khusro A, Aarti C, Rivas-Caceres RR, Barbabosa-Pliego A. Equine Herpesvirus-I Infection in Horses: Recent Updates on its Pathogenicity, Vaccination, and Preventive Management Strategies. J Equine Vet Sci 2020;87:102923.

10.1016/j.jevs.2020.10292332172913

Black WD, Wilcox RS, Stevenson RA, Hartley CA, Ficorilli NP, Gilkerson JR, et al. Prevalence of serum neutralising antibody to equine rhinitis A virus (ERAV), equine rhinitis B virus 1 (ERBV1) and ERBV2. Vet Microbiol 2007;119:65-71.

10.1016/j.vetmic.2006.08.03117046179

Moghaddam S, Shayegh J, Hassanpour A. Seroprevalence of Streptococcus equi subsp. equi in racing horses. Online J Vet Res 2017;21:559-63.

Ivens PAS, Pirie S. Streptococcus equi subspecies equi diagnosis. Equine Vet J 2021;53:15-7.

10.1111/evj.1331932772398

Information

Publisher :The Korean Society for Microbiology and The Korean Society of Virology
Publisher(Ko) :대한미생물학회‧대한바이러스학회
Journal Title :JOURNAL OF BACTERIOLOGY AND VIROLOGY
Volume : 52
No :3
Pages :128-135
Received Date : 2022-03-23
Revised Date : 2022-08-30
Accepted Date : 2022-09-06
DOI :https://doi.org/10.4167/jbv.2022.52.3.128

JOURNAL OF BACTERIOLOGY AND VIROLOGY ISSN:1598-2467(Print) 2093-0429(Online)

All Issue